724 related articles for article (PubMed ID: 27401536)
41. Can scintimammography with (99m)Tc-MIBI identify multifocal and multicentric primary breast cancer?
Cwikla JB; Buscombe JR; Holloway B; Parbhoo SP; Davidson T; McDermott N; Hilson AJ
Nucl Med Commun; 2001 Dec; 22(12):1287-93. PubMed ID: 11711898
[TBL] [Abstract][Full Text] [Related]
42. Comparison of mammography, ultrasound, and MRI in size assessment of ductal carcinoma in situ with histopathologic correlation.
Baek SH; Choi WJ; Cha JH; Kim HH; Shin HJ; Chae EY
Acta Radiol; 2017 Dec; 58(12):1434-1441. PubMed ID: 28281788
[TBL] [Abstract][Full Text] [Related]
43. Impact of Preoperative Breast MR Imaging and MR-guided Surgery on Diagnosis and Surgical Outcome of Women with Invasive Breast Cancer with and without DCIS Component.
Kuhl CK; Strobel K; Bieling H; Wardelmann E; Kuhn W; Maass N; Schrading S
Radiology; 2017 Sep; 284(3):645-655. PubMed ID: 28445683
[TBL] [Abstract][Full Text] [Related]
44. [99m Tc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts].
Mulero F; Nicolás F; Castellón MI; Fuentes T; de la Cruz P; Roca V; Abad L; Nuño de La Rosa JA
Rev Esp Med Nucl; 2000 Sep; 19(5):344-9. PubMed ID: 11062110
[TBL] [Abstract][Full Text] [Related]
45. Background uptake of breast-specific gamma imaging: correlation with mammographic breast density and background enhancement of breast MRI.
Kim MY; Choi N; Ko SM; Chung HW
Clin Imaging; 2014; 38(3):255-8. PubMed ID: 24461560
[TBL] [Abstract][Full Text] [Related]
46. Comparative Diagnostic Utility of Low-Dose Breast-Specific Gamma Imaging to Current Clinical Standard.
Kuhn KJ; Rapelyea JA; Torrente J; Teal CB; Brem RF
Breast J; 2016; 22(2):180-8. PubMed ID: 26662297
[TBL] [Abstract][Full Text] [Related]
47. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
48. Complementary role of semiquantitative analysis of breast-specific gamma imaging in the diagnosis of breast cancer.
Park KS; Chung HW; Yoo YB; Yang JH; Choi N; So Y
AJR Am J Roentgenol; 2014 Mar; 202(3):690-5. PubMed ID: 24555609
[TBL] [Abstract][Full Text] [Related]
49. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
[TBL] [Abstract][Full Text] [Related]
50. Visual and semi-quantitative analyses of dual-phase breast-specific gamma imaging with Tc-99m-sestamibi in detecting primary breast cancer.
Tan H; Jiang L; Gu Y; Xiu Y; Han L; Wu P; Zhang H; Shi H
Ann Nucl Med; 2014 Jan; 28(1):17-24. PubMed ID: 24142630
[TBL] [Abstract][Full Text] [Related]
51. Comparison of breast specific gamma imaging and molecular breast tomosynthesis in breast cancer detection: Evaluation in phantoms.
Gong Z; Williams MB
Med Phys; 2015 Jul; 42(7):4250-9. PubMed ID: 26133623
[TBL] [Abstract][Full Text] [Related]
52. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging.
Satake H; Shimamoto K; Sawaki A; Niimi R; Ando Y; Ishiguchi T; Ishigaki T; Yamakawa K; Nagasaka T; Funahashi H
Eur Radiol; 2000; 10(11):1726-32. PubMed ID: 11097398
[TBL] [Abstract][Full Text] [Related]
53. Breast-specific gamma imaging of invasive breast cancer: Clinicopathologic factors affecting detectability and correlation with mammographic findings.
Park JY; Chun KA; Shin HJ; Yi SY; Kwon HJ; Park HJ
Clin Imaging; 2018; 51():168-173. PubMed ID: 29857225
[TBL] [Abstract][Full Text] [Related]
54. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
55. Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care.
Zhou M; Johnson N; Blanchard D; Bryn S; Nelson J
Am J Surg; 2008 May; 195(5):631-5; discussion 635. PubMed ID: 18374889
[TBL] [Abstract][Full Text] [Related]
56. Molecular Breast Imaging: A Comprehensive Review.
Huppe AI; Mehta AK; Brem RF
Semin Ultrasound CT MR; 2018 Feb; 39(1):60-69. PubMed ID: 29317040
[TBL] [Abstract][Full Text] [Related]
57. Digital volumetric measurement of mammographic density and the risk of overlooking cancer in Japanese women.
Sawada T; Akashi S; Nakamura S; Kuwayama T; Enokido K; Yoshida M; Hashimoto R; Ide T; Masuda H; Taruno K; Oyama H; Takamaru T; Kanada Y; Ikeda M; Kosugi N; Sato H; Nakayama S; Ata A; Tonouchi Y; Sakai H; Matsunaga Y; Matsutani A
Breast Cancer; 2017 Sep; 24(5):708-713. PubMed ID: 28238177
[TBL] [Abstract][Full Text] [Related]
58. The role of technetium-99m methoxyisobutylisonitrile scintimammography in diagnosis of breast cancer in patients with mammographically dense breasts.
Sun SS; Hsieh JF; Tsai SC; Ho YJ; Kao CH
Anticancer Res; 2000; 20(5C):3755-8. PubMed ID: 11268450
[TBL] [Abstract][Full Text] [Related]
59. Breast-specific gamma-imaging: molecular imaging of the breast using 99mTc-sestamibi and a small-field-of-view gamma-camera.
Jones EA; Phan TD; Blanchard DA; Miley A
J Nucl Med Technol; 2009 Dec; 37(4):201-5. PubMed ID: 19914975
[TBL] [Abstract][Full Text] [Related]
60. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Riedl CC; Luft N; Bernhart C; Weber M; Bernathova M; Tea MK; Rudas M; Singer CF; Helbich TH
J Clin Oncol; 2015 Apr; 33(10):1128-35. PubMed ID: 25713430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
